BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35182206)

  • 1. Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer.
    Alshak MN; Eidelberg A; Diaz SM; Stoddard MD; Formenti S; Nagar H; Kang J; Chughtai B
    World J Urol; 2022 May; 40(5):1143-1150. PubMed ID: 35182206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SpaceOAR hydrogel spacer injection prior to stereotactic body radiation therapy for men with localized prostate cancer: A systematic review.
    Payne HA; Pinkawa M; Peedell C; Bhattacharyya SK; Woodward E; Miller LE
    Medicine (Baltimore); 2021 Dec; 100(49):e28111. PubMed ID: 34889268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes.
    Hwang ME; Mayeda M; Liz M; Goode-Marshall B; Gonzalez L; Elliston CD; Spina CS; Padilla OA; Wenske S; Deutsch I
    Radiat Oncol; 2019 Aug; 14(1):136. PubMed ID: 31375119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy.
    Hwang ME; Black PJ; Elliston CD; Wolthuis BA; Smith DR; Wu CC; Wenske S; Deutsch I
    Radiat Oncol; 2018 Oct; 13(1):192. PubMed ID: 30285812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy.
    Wu SY; Boreta L; Wu A; Cheung JP; Cunha JAM; Shinohara K; Chang AJ
    Brachytherapy; 2018; 17(2):259-264. PubMed ID: 29203149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying the impact of SpaceOAR hydrogel on inter-fractional rectal and bladder dose during 0.35 T MR-guided prostate adaptive radiotherapy.
    Farjam R; Mahase SS; Chen SL; Coonce M; Pennell RT; Fecteau R; Chughtai B; Dewyngaert JK; Kang J; Ch Formenti S; Nagar H
    J Appl Clin Med Phys; 2021 Sep; 22(9):49-58. PubMed ID: 34342134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dosimetric impact of hydrogel spacer use for stereotactic body radiotherapy of localised prostate cancer].
    Ung M; Bossi A; Abbassi L; Vautier J; Anthonipillai V; Chevé M; Blanchard P
    Cancer Radiother; 2021 May; 25(3):237-241. PubMed ID: 33419606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes.
    Alongi F; Rigo M; Figlia V; Cuccia F; Giaj-Levra N; Nicosia L; Ricchetti F; Vitale C; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Mazzola R
    Br J Radiol; 2021 Jan; 94(1117):20200848. PubMed ID: 33095659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal protection in prostate stereotactic radiotherapy: a retrospective exploratory analysis of two rectal displacement devices.
    Wilton L; Richardson M; Keats S; Legge K; Hanlon MC; Arumugam S; Hunter P; Evans TJ; Sidhom M; Martin J
    J Med Radiat Sci; 2017 Dec; 64(4):266-273. PubMed ID: 28786219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
    Hwang ME; Mayeda M; Shaish H; Elliston CD; Spina CS; Wenske S; Deutsch I
    Br J Radiol; 2021 Mar; 94(1119):20200433. PubMed ID: 33586999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision analysis model evaluating the cost of a temporary hydrogel rectal spacer before prostate radiation therapy to reduce the incidence of rectal complications.
    Hutchinson RC; Sundaram V; Folkert M; Lotan Y
    Urol Oncol; 2016 Jul; 34(7):291.e19-26. PubMed ID: 27038698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison.
    Ogita M; Yamashita H; Nozawa Y; Ozaki S; Sawayanagi S; Ohta T; Nakagawa K
    Radiat Oncol; 2021 Jun; 16(1):107. PubMed ID: 34118956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric and clinical outcomes of SpaceOAR in men undergoing external beam radiation therapy for localized prostate cancer: A systematic review.
    Babar M; Katz A; Ciatto M
    J Med Imaging Radiat Oncol; 2021 Jun; 65(3):384-397. PubMed ID: 33855816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution analysis of hydrogel spacer and evaluation of rectal dose reduction in Japanese prostate cancer patients undergoing stereotactic body radiation therapy.
    Kobayashi H; Eriguchi T; Tanaka T; Ogata T; Ishida M; Nakajima Y; Kumabe A; Kosugi M
    Int J Clin Oncol; 2021 Apr; 26(4):736-743. PubMed ID: 33415570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prostate cancer.
    Sawayanagi S; Yamashita H; Ogita M; Takenaka R; Nozawa Y; Watanabe Y; Imae T; Abe O
    Radiat Oncol; 2022 Feb; 17(1):41. PubMed ID: 35197092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.
    Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Hamstra DA; Bosch W; Gay H; Michalski J
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):971-977. PubMed ID: 26054865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved irritative voiding symptoms 3 years after stereotactic body radiation therapy for prostate cancer.
    Rana Z; Cyr RA; Chen LN; Kim BS; Moures RA; Yung TM; Lei S; Collins BT; Suy S; Dritschilo A; Lynch JH; Collins SP
    Front Oncol; 2014; 4():290. PubMed ID: 25374844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute patient-reported bowel quality of life and rectal bleeding with the combination of prostate external beam radiation, low-dose-rate brachytherapy boost, and SpaceOAR.
    Patel AK; Houser C; Benoit R; Smith RP; Beriwal S
    Brachytherapy; 2020; 19(4):477-483. PubMed ID: 32331976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposed Hydrogel-Implant Quality Score and a Matched-Pair Study for Prostate Radiation Therapy.
    Liu H; Borden L; Wiant D; Sintay B; Hayes L; Manning M
    Pract Radiat Oncol; 2020; 10(3):202-208. PubMed ID: 32088428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of Iodinated SpaceOAR Vue™ During Robotic Prostate Stereotactic Body Radiation Therapy (SBRT) to Identify the Rectal-Prostate Interface and Spare the Rectum: A Case Report.
    Conroy D; Becht K; Forsthoefel M; Pepin AN; Lei S; Rashid A; Collins BT; Lischalk JW; Suy S; Aghdam N; Hankins RA; Collins SP
    Front Oncol; 2020; 10():607698. PubMed ID: 33489918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.